/
•
•
Context is everything.
Detailed stories on technology startups, business and economic current affairs.
Detailed stories on technology startups, business and economic current affairs.
The online drugs and medical services startup made some costly acquisitions in a bid to pull off an IPO at a high valuation. That plan may be coming unstuck.
On Monday, Reuters reported that online drugs and medical services startup PharmEasy was looking to raise $200 million. What was disturbing was that the company was prepared to do it at a lower valuation than it last raised money at.
That PharmEasy would want to raise $200 million was first reported in The Economic Times in May, when the company was in talks with Goldman Sachs to raise a debt of Rs 2,700 crore (about $340 million). The Reuters report said PharmEasy was open to offering a 15% or even 25% discount to last year's $5.1 billion valuation.
Clearly, PharmEasy’s …
Who’s going to lead the IPO party, what’s going to drive the market, where are some of the leading businesses headed, and more.
Finally, this question will be answered. Who has returned the most amount of capital on any venture investment in India in the last two decades?
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
